Clinical Trials Browser

Phase 2 × Terminated × VAP-cyclo protocol × Clear all

NCT03145480 2023-06-01

Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients

Phase 2 Terminated

3 enrolled 5 charts

Other hematologic neoplasm

Leukemia